MedPath
NMPA Approval

Levodropropizine Oral Solution

国药准字H20193049

September 11, 2024

Drug Information

左羟丙哌嗪口服溶液

口服溶液剂

10ml:60mg

化学药品

September 11, 2024

Company Information

Applicant Company

北京市顺义区天竺空港工业区A区天柱西路10号

Manufacturing Company

北京市顺义区天竺空港工业区A区天柱西路10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左羟丙哌嗪口服溶液 - NMPA 批准文号 | MedPath